Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial

被引：0
|
作者：
Lutz van Heek
Colin Stuka
Helen Kaul
Horst Müller
Jasmin Mettler
Felicitas Hitz
Christian Baues
Michael Fuchs
Peter Borchmann
Andreas Engert
Markus Dietlein
Conrad-Amadeus Voltin
Carsten Kobe
机构：
[1] University of Cologne,Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne
[2] University of Cologne,First Department of Internal Medicine and German Hodgkin Study Group (GHSG), Center for Integrated Oncology Aachen – Bonn – Cologne – Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne
[3] Swiss Group for Clinical Cancer Research,Department of Medical Oncology and Haematology
[4] Kantonsspital St.Gallen,Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and UniversityHospital Cologne
[5] University of Cologne,undefined
来源：
BMC Cancer | / 22卷
关键词：
Hodgkin lymphoma; Metabolic tumor volume; FDG PET; Response prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial
    van Heek, Lutz
    Stuka, Colin
    Kaul, Helen
    Mueller, Horst
    Mettler, Jasmin
    Hitz, Felicitas
    Baues, Christian
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    Dietlein, Markus
    Voltin, Conrad-Amadeus
    Kobe, Carsten
    BMC CANCER, 2022, 22 (01)
  • [2] Prognostic Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma - Data from the Prospective, Multicenter Phase III HD16 Trial
    van Heek, Lutz
    Stuka, Colin
    Mueller, Horst
    Kaul, Helen
    Mettler, Jasmin
    Hitz, Felicitas
    Baues, Christian
    Fuchs, Michael
    Borchmann, Peter
    Voltin, Conrad-Amadeus
    Engert, Andreas
    Dietlein, Markus
    Kobe, Carsten
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [3] Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial
    van Heek, Lutz
    Weindler, Jasmin
    Gorniak, Claudia
    Kaul, Helen
    Mueller, Horst
    Mettler, Jasmin
    Baues, Christian
    Fuchs, Michael
    Borchmann, Peter
    Ferdinandus, Justin
    Dietlein, Markus
    Voltin, Conrad-Amadeus
    Kobe, Carsten
    Roth, Katrin S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 881 - 887
  • [4] Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
    Fuchs, Michael
    Jacob, Anne Sophie
    Kaul, Helen
    Kobe, Carsten
    Kuhnert, Georg
    Pabst, Thomas
    Greil, Richard
    Broeckelmann, Paul J.
    Topp, Max S.
    Just, Marianne
    Hertenstein, Bernd
    Soekler, Martin
    Vogelhuber, Martin
    Zijlstra, Josee M.
    Keller, Ulrich Bernd
    Krause, Stefan W.
    Duehrsen, Ulrich
    Meissner, Julia
    Viardot, Andreas
    Eich, Hans-Theodor
    Baues, Christian
    Diehl, Volker
    Rosenwald, Andreas
    Buehnen, Ina
    von Tresckow, Bastian
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    Eichenauer, Dennis A.
    LEUKEMIA, 2024, 38 (01) : 160 - 167
  • [5] Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
    Michael Fuchs
    Anne Sophie Jacob
    Helen Kaul
    Carsten Kobe
    Georg Kuhnert
    Thomas Pabst
    Richard Greil
    Paul J. Bröckelmann
    Max S. Topp
    Marianne Just
    Bernd Hertenstein
    Martin Soekler
    Martin Vogelhuber
    Josée M. Zijlstra
    Ulrich Bernd Keller
    Stefan W. Krause
    Ulrich Dührsen
    Julia Meissner
    Andreas Viardot
    Hans-Theodor Eich
    Christian Baues
    Volker Diehl
    Andreas Rosenwald
    Ina Buehnen
    Bastian von Tresckow
    Markus Dietlein
    Peter Borchmann
    Andreas Engert
    Dennis A. Eichenauer
    Leukemia, 2024, 38 (1) : 160 - 167
  • [6] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
    Eich, H. T.
    Baues, C.
    Fuchs, M.
    Kobe, C.
    Greil, R.
    Sasse, S.
    Zijlstra, J. M.
    Lohri, A.
    Rosenwald, A.
    Tresckow, B. V.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Borchmann, P.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S1 - S1
  • [7] Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Kuhnert, Georg
    Lohri, Andreas
    Greil, Richard
    Sasse, Stephanie
    Topp, Max S.
    Schaefer, Erhardt
    Hertenstein, Bernd
    Soekler, Martin
    Vogelhuber, Martin
    Zijlstra, Josee M.
    Keller, Ulrich Bernd
    Krause, Stefan W.
    Wilhelm, Martin
    Maschmeyer, Georg
    Thiemer, Julia
    Duehrsen, Ulrich
    Meissner, Julia
    Viardot, Andreas
    Eich, Hans
    Baues, Christian
    Diehl, Volker
    Rosenwald, Andreas
    von Tresckow, Bastian
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2835 - +
  • [8] Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
    Cottereau, Anne-Segolene
    Versari, Annibale
    Loft, Annika
    Casasnovas, Olivier
    Bellei, Monica
    Ricci, Romain
    Bardet, Stephane
    Castagnoli, Antonio
    Brice, Pauline
    Raemaekers, John
    Deau, Benedicte
    Fortpied, Catherine
    Raveloarivahy, Tiana
    Van Zele, Emelie
    Chartier, Loic
    Borght, Thierry Vander
    Federico, Massimo
    Hutchings, Martin
    Ricardi, Umberto
    Andre, Marc
    Meignan, Michel
    BLOOD, 2018, 131 (13) : 1456 - 1463
  • [9] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Eich, Hans
    Baues, Christian
    Greil, Richard
    Sasse, Stephanie
    Zijlstra, Josee M.
    Lohri, Andreas
    Rosenwald, Andreas
    von Tresckow, Bastian
    Diehl, Volker
    Kuhnert, Georg
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2018, 132
  • [10] PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial by the German Hodgkin Study Group
    Jacob, Anne Sophie
    Fuchs, Michael
    Kaul, Helen
    Kobe, Carsten
    Pabst, Thomas
    Greil, Richard
    Eichenauer, Dennis
    Topp, Max
    Just, Marianne
    Hertenstein, Bernd
    Schaub, Valdete
    Vogelhuber, Martin
    Zijlstra, Josee M.
    Pluetschow, Annette
    Baues, Christian
    Rosenwald, Andreas
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 168 - 168
12345